AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Factors associated with transitioning from post-exposure prophylaxis to pre-exposure prophylaxis at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: A five-year observational cohortView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Starting PrEP during acute HIV infection: what is the risk for antiretroviral drug resistance?View Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019A mathematical model of HIV prevention strategies in Japanese MSMView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Practical perspective of the use of point-of-care testing for supporting the delivery of HIV pre-exposure prophylaxisView Abstract
VideoRSVHIVViral Hepatitis and Liver DiseaseAPACC 2019Provider’s perspective of PrEP demedicalizationView Video
VideoRSVHIVViral Hepatitis and Liver DiseaseAPACC 2019Overview of Clinical Trials for HIV Cure - James McMahonView Video
VideoRSVHIVViral Hepatitis and Liver DiseaseAPACC 2019Controversies in Management of Latent TB Infection in HIV-Positive People - Chi Chiu LeungView Video
VideoRSVHIVViral Hepatitis and Liver DiseaseAPACC 2019Key Pop-Led HIV Service Delivery: Focus on Transgenders - Rena JanamnuaysookView Video
VideoRSVHIVViral Hepatitis and Liver DiseaseAPACC 2019Key Population Community Engagement - Matthew AveryView Video
VideoRSVHIVViral Hepatitis and Liver DiseaseAPACC 2019Provider's Perspective of PrEP Demedicalization - Heather Marie SchmidtView Video
VideoRSVHIVViral Hepatitis and Liver DiseaseAPACC 2019Minimum STI Package in HIV Care and Prevention for LMIC - Reshmie RamautarsingView Video
VideoRSVHIVViral Hepatitis and Liver DiseaseAPACC 2019Prevention of Cyptococcosis and Other AIDS-Related Fungal Infections - David BoulwareView Video
